Weill Cornell Presents Updated Results From Phase 3 Trial Of IVIG For Alzheimer's Disease

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer’s disease at the Alzheimer’s Association International Conference (AAIC) in Boston, Mass… Read & Research Alzheimer’s More

Leave a Reply